[ Price : $8.95]
FDA approves a Boehringer Ingelheim NDA for Spevigo (spesolimab) as a treatment option for generalized pustular psoriasis flares i...[ Price : $8.95]
Federal Register notice: FDA advisory committee reviews GlaxoSmithKline NDA for daprodustat, indicated for treating anemia due to ...[ Price : $8.95]
FDA approves an Azurity Pharmaceuticals NDA for Konvomep (omeprazole and sodium bicarbonate for oral suspension), a proton pump in...[ Price : $8.95]
FDA grants Vibrant Gastro de novo marketing authorization for its Vibrant, an orally administered drug-free capsule that provides ...[ Price : $8.95]
FDA approves an AstraZeneca supplemental BLA for Imfinzi (durvalumab) for combination use with gemcitabine and cisplatin for adult...[ Price : $8.95]
Federal Register notice: FDA announces an 11/8 Pulmonary-Allergy Drugs Advisory Committee meeting to review AstraZeneca NDA for a ...[ Price : $8.95]
FDA reviewers dismiss new analyses and data from Amylyx that were intended to provide confirmatory evidence to support approval of...[ Price : $8.95]
FDA issues a form FDA-483 with multiple inspection observations to Indias Biocon Biologics following three inspections at manufact...